Humana Inc. (HUM) Given New $217.00 Price Target at Royal Bank Of Canada
Humana Inc. (NYSE:HUM) had its target price lowered by Royal Bank Of Canada from $222.00 to $217.00 in a research report released on Thursday. The firm currently has a sector perform rating on the insurance provider’s stock.
A number of other analysts have also recently issued reports on HUM. Cantor Fitzgerald reiterated a buy rating on shares of Humana in a research note on Saturday, July 9th. RBC Capital Markets reiterated a buy rating and issued a $224.00 target price (up from $220.00) on shares of Humana in a research note on Friday, July 22nd. Jefferies Group reduced their target price on shares of Humana from $220.00 to $217.00 and set a buy rating for the company in a research note on Thursday, August 4th. Barclays PLC reduced their target price on shares of Humana from $193.00 to $191.00 and set an equal weight rating for the company in a research note on Thursday, August 4th. Finally, Evercore ISI assumed coverage on shares of Humana in a research note on Thursday, September 22nd. They issued a buy rating and a $200.00 target price for the company. Seven analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. Humana presently has an average rating of Buy and a consensus target price of $200.50.
Humana (NYSE:HUM) traded up 1.59% on Thursday, reaching $172.17. 484,518 shares of the company’s stock were exchanged. Humana has a 12 month low of $150.00 and a 12 month high of $191.65. The firm has a 50 day moving average of $176.12 and a 200 day moving average of $175.83. The stock has a market capitalization of $25.66 billion, a PE ratio of 26.45 and a beta of 0.90.
Humana (NYSE:HUM) last posted its earnings results on Wednesday, August 3rd. The insurance provider reported $2.30 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.23 by $0.07. The firm earned $14 billion during the quarter, compared to analysts’ expectations of $13.59 billion. Humana had a net margin of 1.76% and a return on equity of 11.11%. The company’s revenue was up 2.0% compared to the same quarter last year. During the same period in the previous year, the company earned $1.67 earnings per share. Equities analysts predict that Humana will post $9.24 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Thursday, October 13th will be paid a $0.29 dividend. The ex-dividend date of this dividend is Tuesday, October 11th. This represents a $1.16 dividend on an annualized basis and a dividend yield of 0.68%. Humana’s dividend payout ratio (DPR) is presently 18.18%.
A number of hedge funds have recently bought and sold shares of the company. RidgeWorth Capital Management LLC acquired a new stake in Humana during the second quarter worth about $75,609,000. FMR LLC boosted its stake in Humana by 21.5% in the second quarter. FMR LLC now owns 1,876,497 shares of the insurance provider’s stock worth $337,544,000 after buying an additional 331,537 shares during the last quarter. Renaissance Technologies LLC boosted its stake in Humana by 246.3% in the first quarter. Renaissance Technologies LLC now owns 446,000 shares of the insurance provider’s stock worth $81,596,000 after buying an additional 317,200 shares during the last quarter. Adage Capital Partners GP L.L.C. boosted its stake in Humana by 39.4% in the first quarter. Adage Capital Partners GP L.L.C. now owns 940,360 shares of the insurance provider’s stock worth $172,039,000 after buying an additional 265,700 shares during the last quarter. Finally, BlackRock Investment Management LLC boosted its stake in Humana by 34.3% in the second quarter. BlackRock Investment Management LLC now owns 950,666 shares of the insurance provider’s stock worth $171,006,000 after buying an additional 242,769 shares during the last quarter. 93.24% of the stock is owned by institutional investors and hedge funds.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Stock Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related stocks with our FREE daily email newsletter.